(Q333722)

Statements

0 references

addresses subject

Diagnosis and Treatment of Multiple Myeloma

777

1 reference

https://openalex.org/I4210151386

Health Economics and Quality of Life Assessment

753

1 reference

https://openalex.org/I4210151386

Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia

636

1 reference

https://openalex.org/I4210151386

Therapeutic Antibodies: Development, Engineering, and Applications

599

1 reference

https://openalex.org/I4210151386

Schizophrenia Research and Treatment

478

1 reference

https://openalex.org/I4210151386

Advancements in Prostate Cancer Research

474

1 reference

https://openalex.org/I4210151386

Genetics and Treatment of Inflammatory Bowel Disease

451

1 reference

https://openalex.org/I4210151386

Reciprocal Development of TH17 and Treg Cells

449

1 reference

https://openalex.org/I4210151386

Atrial Fibrillation group of topics

437

1 reference

https://openalex.org/I4210151386

Management of Diabetes Mellitus and Cardiovascular Risk

428

1 reference

https://openalex.org/I4210151386

Statistical Methods in Clinical Trials and Drug Development

404

1 reference

https://openalex.org/I4210151386

Immunogenicity of Biosimilar Therapeutics in Drug Development

392

1 reference

https://openalex.org/I4210151386

Rheumatoid Arthritis Topics

380

1 reference

https://openalex.org/I4210151386

Lymphoid Neoplasms

330

1 reference

https://openalex.org/I4210151386

Developmental Pharmacology in Pediatric Drug Use

319

1 reference

https://openalex.org/I4210151386

Chimeric Antigen Receptor T Cell Therapy

318

1 reference

https://openalex.org/I4210151386

Molecular Mechanisms of Depression Treatment Strategies

303

1 reference

https://openalex.org/I4210151386

Prevention and Treatment of Venous Thromboembolism

300

1 reference

https://openalex.org/I4210151386

Diagnosis and Management of Alzheimer's Disease

260

1 reference

https://openalex.org/I4210151386

Efficacy and Safety of Antiretroviral Therapy for HIV

254

1 reference

https://openalex.org/I4210151386

Targeted Protein Degradation in Biomedical Research

245

1 reference

https://openalex.org/I4210151386

Development and Applications of Radiopharmaceuticals

241

1 reference

https://openalex.org/I4210151386

Epidemiology and Management of Bipolar Disorder

236

1 reference

https://openalex.org/I4210151386

Computational Methods in Drug Discovery

233

1 reference

https://openalex.org/I4210151386

Hemophagocytic Lymphohistiocytosis and Related Disorders

229

1 reference

https://openalex.org/I4210151386

coordinate location

40°23'21"N, 74°45'43"W

1 reference

https://openalex.org/I4210151386

United States of America

1 reference

https://openalex.org/I4210151386

official website

http://www.janssen.com/us/

1 reference

https://openalex.org/I4210151386

0 references

Research Organization Registry ID

0 references

is subsidiary of

Johnson & Johnson (United States)

1 reference

https://openalex.org/I4210151386

Retrieved from "https://geokb.wikibase.cloud/w/index.php?title=Item:Q333722&oldid=1270132"